Citius Pharmaceuticals, Inc. (CTXR)
0.8877
-0.01
(-1.37%)
USD |
NASDAQ |
Jan 09, 16:00
0.8686
-0.02
(-2.15%)
After-Hours: 20:00
Citius Pharmaceuticals Total Liabilities (Quarterly): 53.63M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Citius Oncology, Inc. | 56.08M |
| Dynavax Technologies Corp. | 412.37M |
| Applied Therapeutics, Inc. | 34.94M |
| Dermata Therapeutics, Inc. | 1.111M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 131.16M |
| Shareholders Equity (Quarterly) | 67.55M |
| Debt to Equity Ratio | 0.0268 |
| Current Ratio | 0.6219 |
| Net Debt Paydown Yield | -1.33% |